Ad
related to: pfizer 2023 results live 2021insights.pfizer.com has been visited by 10K+ users in the past month
Search results
Results From The WOW.Com Content Network
Pfizer is due to report its third-quarter earnings on Nov. 1. Julie Hyman is the co-anchor of Yahoo Finance Live, weekdays 9am-11am ET . Follow her on Twitter @juleshyman , and read her other stories.
In September 2023, the FDA approved an updated monovalent (single) component Omicron variant XBB.1.5 version of the vaccine (Comirnaty 2023–2024 formula) as a single dose for individuals aged twelve years of age and older; [30] and authorized the Pfizer-BioNTech COVID-19 Vaccine 2023–2024 formula under emergency use for individuals aged 6 ...
COVID-19 gave a shot in the arm to Pfizer's sales and culture. Now CEO Albert Bourla lays out a plan to replace vaccine revenue as the virus' impact wanes. Pfizer CEO: 2023 will be a 'pivotal year ...
The drugmaker said it now expects 2023 revenue of between $58 billion and $61 billion, down from it prior forecast of $67 billion to $70 billion. It said the reduction was solely due to lowered ...
BioNTech was founded in 2008 based on research by Uğur Şahin, Özlem Türeci, [8] and Christoph Huber, [9] with a seed investment of €180 million [10] from MIG Capital, a Munich-based venture capital firm, the family office of Andreas and Thomas Strüngmann, and the present chairman of the supervisory board, Helmut Jeggle.
In August 2022, Pfizer and Valneva initiated the currently ongoing Phase 3 clinical study, Vaccine Against Lyme for Outdoor Recreationists (VALOR) (NCT05477524), to investigate the efficacy, safety and immunogenicity of VLA15 in participants five years of age and older in highly endemic regions in the United States (U.S.) and Europe. 3 The ...
Pfizer Inc. now foresees 2023 revenue in a range of $58 billion to $61 billion, down from its prior forecast for $67 billion to $70 billion. It now projects full-year adjusted earnings between $1. ...
The Malaysian Government announced that it would buy stocks of the Pfizer-BioNTech COVID-19 vaccine for children after a panel of advisers to the United States Food and Drug Administration recommended that the vaccine be authorised for children aged between 5 and 11 years.